Michael Towers is an Investment Director at Bridgepoint Development Capital, a position they have held since 2020. They currently serve as a Non-Executive Director at Fera Science Ltd. and Prescient Healthcare Group, and were a Board Member at Analysys Mason from 2022 to 2023. Previously, Michael worked as an M&A Analyst at HSBC in 2012 and held various roles at Bridgepoint. Michael earned a Bachelor's Degree in English Language and Literature from the University of Oxford and has received merits in Grade 8 Piano and Grade 5 Music Theory and Composition from ABRSM.
Location
London, United Kingdom